Neuroinflammation in Alzheimer's Disease: Insights from Peripheral Immune Cells

Overview

Journal Immun Ageing

Publisher Biomed Central

Specialty Geriatrics

Date 2024 Jun 14

PMID 38877498

Authors

Qiang Zhang

Guanhu Yang

Yuan Luo

Lai Jiang

Hao Chi

Gang Tian

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a serious brain disorder characterized by the presence of beta-amyloid plaques, tau pathology, inflammation, neurodegeneration, and cerebrovascular dysfunction. The presence of chronic neuroinflammation, breaches in the blood-brain barrier (BBB), and increased levels of inflammatory mediators are central to the pathogenesis of AD. These factors promote the penetration of immune cells into the brain, potentially exacerbating clinical symptoms and neuronal death in AD patients. While microglia, the resident immune cells of the central nervous system (CNS), play a crucial role in AD, recent evidence suggests the infiltration of cerebral vessels and parenchyma by peripheral immune cells, including neutrophils, T lymphocytes, B lymphocytes, NK cells, and monocytes in AD. These cells participate in the regulation of immunity and inflammation, which is expected to play a huge role in future immunotherapy. Given the crucial role of peripheral immune cells in AD, this article seeks to offer a comprehensive overview of their contributions to neuroinflammation in the disease. Understanding the role of these cells in the neuroinflammatory response is vital for developing new diagnostic markers and therapeutic targets to enhance the diagnosis and treatment of AD patients.

Citing Articles

From pixels to prognosis: radiomics and AI in Alzheimer's disease management.

Peng D, Huang W, Liu R, Zhong W Front Neurol. 2025; 16:1536463.

PMID: 39944545 PMC: 11816362. DOI: 10.3389/fneur.2025.1536463.

Skull bone marrow and skull meninges channels: redefining the landscape of central nervous system immune surveillance.

Liu L, Zhang X, Chai Y, Zhang J, Deng Q, Chen X Cell Death Dis. 2025; 16(1):53.

PMID: 39875352 PMC: 11775313. DOI: 10.1038/s41419-025-07336-2.

The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications.

Kim S, Jung U, Kim S J Clin Med. 2025; 14(2).

PMID: 39860392 PMC: 11765772. DOI: 10.3390/jcm14020386.

The effects of loss of Y chromosome on male health.

Bruhn-Olszewska B, Markljung E, Rychlicka-Buniowska E, Sarkisyan D, Filipowicz N, Dumanski J Nat Rev Genet. 2025; .

PMID: 39743536 DOI: 10.1038/s41576-024-00805-y.

Immunotherapy and pan-apoptotic characterization of the tumor microenvironment in gastric cancer (STAD): a single-cell multidimensional analysis.

Zhang S, Wang J, Zhang H, Li B, Gao S Discov Oncol. 2024; 15(1):550.

PMID: 39397186 PMC: 11471748. DOI: 10.1007/s12672-024-01429-8.

References

Gruden M, Davidova T, Malisauskas M, Sewell R, Voskresenskaya N, Wilhelm K . Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters. J Neuroimmunol. 2007; 186(1-2):181-92. DOI: 10.1016/j.jneuroim.2007.03.023. View

Aratani Y . Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018; 640:47-52. DOI: 10.1016/j.abb.2018.01.004. View

Marsh S, Abud E, Lakatos A, Karimzadeh A, Yeung S, Davtyan H . The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proc Natl Acad Sci U S A. 2016; 113(9):E1316-25. PMC: 4780638. DOI: 10.1073/pnas.1525466113. View

Jianping L, Zhibing Y, Wei Q, Zhikai C, Jie X, Jinbiao L . Low avidity and level of serum anti-Abeta antibodies in Alzheimer disease. Alzheimer Dis Assoc Disord. 2006; 20(3):127-32. DOI: 10.1097/00002093-200607000-00001. View

Zhang Y, Liu M, Sun H, Yin K . Matrine improves cognitive impairment and modulates the balance of Th17/Treg cytokines in a rat model of Aβ1-42-induced Alzheimer's disease. Cent Eur J Immunol. 2016; 40(4):411-9. PMC: 4737738. DOI: 10.5114/ceji.2015.56961. View

Naert G, Rivest S . A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease. J Mol Cell Biol. 2013; 5(5):284-93. DOI: 10.1093/jmcb/mjt028. View

Gilman S, Koller M, Black R, Jenkins L, Griffith S, Fox N . Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology. 2005; 64(9):1553-62. DOI: 10.1212/01.WNL.0000159740.16984.3C. View

Baulch J, Acharya M, Agrawal S, Apodaca L, Monteiro C, Agrawal A . Immune and Inflammatory Determinants Underlying Alzheimer's Disease Pathology. J Neuroimmune Pharmacol. 2020; 15(4):852-862. PMC: 7483328. DOI: 10.1007/s11481-020-09908-9. View

Griciuc A, Serrano-Pozo A, Parrado A, Lesinski A, Asselin C, Mullin K . Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013; 78(4):631-43. PMC: 3706457. DOI: 10.1016/j.neuron.2013.04.014. View

10.

Muller G, Lipp M . Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation. 2003; 10(3-4):325-34. DOI: 10.1038/sj.mn.7800197. View

11.

Lu Y, Li K, Hu Y, Wang X . Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer's Disease. Front Immunol. 2021; 12:768966. PMC: 8602845. DOI: 10.3389/fimmu.2021.768966. View

12.

Gherardelli C, Cisternas P, Vera-Salazar R, Mendez-Orellana C, Inestrosa N . Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2022; 87(2):901-917. DOI: 10.3233/JAD-215273. View

13.

Oberstein T, Taha L, Spitzer P, Hellstern J, Herrmann M, Kornhuber J . Imbalance of Circulating T17 and Regulatory T Cells in Alzheimer's Disease: A Case Control Study. Front Immunol. 2018; 9:1213. PMC: 5994416. DOI: 10.3389/fimmu.2018.01213. View

14.

Liang T, Zhang Y, Wu S, Chen Q, Wang L . The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets. Front Pharmacol. 2022; 13:845185. PMC: 8889079. DOI: 10.3389/fphar.2022.845185. View

15.

Saare M, Tserel L, Haljasmagi L, Taalberg E, Peet N, Eimre M . Monocytes present age-related changes in phospholipid concentration and decreased energy metabolism. Aging Cell. 2020; 19(4):e13127. PMC: 7189998. DOI: 10.1111/acel.13127. View

16.

Brines M, Patel N, Villa P, Brines C, Mennini T, De Paola M . Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A. 2008; 105(31):10925-30. PMC: 2504825. DOI: 10.1073/pnas.0805594105. View

17.

Baril L, Nicolas L, Croisile B, Crozier P, Hessler C, Sassolas A . Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects. Neurosci Lett. 2004; 355(3):226-30. DOI: 10.1016/j.neulet.2003.10.071. View

18.

Dong Z, Xu M, Sun X, Wang X . Mendelian randomization and transcriptomic analysis reveal an inverse causal relationship between Alzheimer's disease and cancer. J Transl Med. 2023; 21(1):527. PMC: 10403895. DOI: 10.1186/s12967-023-04357-3. View

19.

Masera R, Prolo P, Sartori M, Staurenghi A, Griot G, Ravizza L . Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease. Psychoneuroendocrinology. 2002; 27(4):447-61. DOI: 10.1016/s0306-4530(01)00062-2. View

20.

Pellicano M, Bulati M, Buffa S, Barbagallo M, Di Prima A, Misiano G . Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. J Alzheimers Dis. 2010; 21(1):181-92. DOI: 10.3233/JAD-2010-091714. View